# Dopaminergic Therapy for Frontotemporal Dementia Patients

> **NCT04937452** · PHASE2 · COMPLETED · sponsor: **I.R.C.C.S. Fondazione Santa Lucia** · enrollment: 75 (actual)

## Conditions studied

- Frontotemporal Dementia
- Dementia
- Aphasia, Primary Progressive
- Pick Disease of the Brain
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neurocognitive Disorders
- Mental Disorders
- Neurodegenerative Diseases
- Frontotemporal Lobar Degeneration
- TDP-43 Proteinopathies
- Proteostasis Deficiencies
- Metabolic Disease
- Aphasia
- Speech Disorders
- Language Disorders
- Communication Disorders
- Neurobehavioral Manifestations
- Neurologic Manifestations

## Interventions

- **DRUG:** Rotigotine 4Mg/24Hrs Patch
- **DRUG:** Rotigotine 6Mg/24Hrs Patch
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04937452
- **Lead sponsor:** I.R.C.C.S. Fondazione Santa Lucia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-03
- **Primary completion:** 2023-12-30
- **Final completion:** 2024-04-01
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2024-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04937452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04937452, "Dopaminergic Therapy for Frontotemporal Dementia Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04937452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*